Paso Robles-based Pearce Services acquires Unified Power
Paso Robles-based Pearce Services will become one of the largest independent service providers for power continuity solutions in the United States after announcing it has acquired Unified Power on Dec. 18. “The acquisition of Unified Power marks a significant milestone in our company’s history,” Michelle Edler, CEO of Pearce Services, said in a press release. Read More →
Judge hands CLU win in Gallegly breach of contract lawsuit
A Ventura County Superior Court judge on Dec. 13 reversed his own intended ruling, handing California Lutheran University a win in its ongoing legal battle with former Congressman Elton Gallegly. Gallegly and his wife, Janice, have sued the Thousand Oaks-based university for breach of contract, alleging it failed to fully establish the Elton and Janice Gallegly Center Read More →
Dubroff: Google’s breakthrough quantum chip has Central Coast ties
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
AeroVironment shares plummet in after-hours trading
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Simi Valley’s new home-grown city manager
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen’s shares down after obesity drug fails to meet expectations
MarTide, the new weight loss drug from Amgen, works. Not just well enough for Wall Street. Shares of the Thousand Oaks-based biotech giant fell 10% on Nov. 26 after it announced that MarTide’s latest trial produced a body weight reduction of up to 20%. The results disappointed Wall Street, which had expected results of up Read More →
